Clinical trial
Testosterone and Growth Hormone for Bone Loss in Men
NCT00080483 · University of Pennsylvania, Other · Completed
Key facts
| NCT number | NCT00080483 |
|---|---|
| Title | Testosterone and Growth Hormone for Bone Loss in Men |
| Official title | Will Testosterone and Growth Hormone Improve Bone Structure? |
| Lead sponsor | University of Pennsylvania, Other |
| Collaborators | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypopituitarism, Hypogonadism, Growth Hormone Deficiency |
| Intervention type | Drug |
| Interventions | Testosterone plus somatropin, testosterone |
| Enrollment | 35 |
| Start date | Mar 1, 2004 |
| Primary completion | Sep 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | Apr 6, 2004 |
| Last update posted | Jun 13, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: